About this trial
The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.
Eligibility criteria
Qualifiers
Patients undergoing Transcatheter Tricuspid Valve Replacement
Native Tricuspid Valve disease
Orthotopic Tricuspid Valve Implantation
Disqualifiers
Age under 18 years
Trial design
Treatments tested in this trial
- Transcatheter Tricuspid Valve Replacement
Treatment groups
Sponsors and collaborators
Montefiore Medical Center
Lead sponsor
The Cleveland Clinic
Collaborator
University of Toronto
Collaborator
University Hospital, Bordeaux
Collaborator